electroCore Announces Publication of PREMIUM II Trial of gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) for the Prevention of Migraine

Stock Information for electroCore Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About electroCore Inc.

electroCore Announces the Launch of Truvaga Plus® for General Wellness
electroCore Expands Intellectual Property Portfolio
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
electroCore to Participate in Upcoming Investor Conferences
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
electroCore Expands Intellectual Property Portfolio
electroCore Expands Intellectual Property Portfolio
electroCore Expands Intellectual Property Portfolio

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.